Literature DB >> 19482064

Selective cognitive deficits and reduced hippocampal brain-derived neurotrophic factor mRNA expression in small-conductance calcium-activated K+ channel deficient mice.

J P R Jacobsen1, J P Redrobe, H H Hansen, S Petersen, C T Bond, J P Adelman, J D Mikkelsen, N R Mirza.   

Abstract

Small-conductance calcium-activated K(+) channels 1-3 (SK1-3) are important for neuronal firing regulation and are considered putative CNS drug targets. For instance non-selective SK blockers improve performance in animal models of cognition. The SK subtype(s) involved herein awaits identification and the question is difficult to address pharmacologically due to the lack of subtype-selective SK-channel modulators. In this study, we used doxycycline-induced conditional SK3-deficient (T/T) mice to address the cognitive consequences of selective SK3 deficiency. In T/T mice SK3 protein is near-eliminated from the brain following doxycycline treatment. We tested T/T and wild type (WT) littermate mice in five distinct learning and memory paradigms. In Y-maze spontaneous alternations and five-trial inhibitory avoidance the performance of T/T mice was markedly inferior to WT mice. In contrast, T/T and WT mice performed equally well in passive avoidance, object recognition and the Morris water maze. Thus, some aspects of working/short-term memory are disrupted in T/T mice. Using in situ hybridization, we further found the cognitive deficits in T/T mice to be paralleled by reduced brain-derived neurotrophic factor (BDNF) mRNA expression in the dentate gyrus and CA3 of the hippocampus. BDNF mRNA levels in the frontal cortex were not affected. BDNF has been crucially implicated in many cognitive processes. Hence, the biological substrate for the cognitive impairments in T/T mice could conceivably entail reduced trophic support of the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482064     DOI: 10.1016/j.neuroscience.2009.05.062

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

1.  Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.

Authors:  Christiane K Bauer; Pauline E Schneeberger; Fanny Kortüm; Janine Altmüller; Fernando Santos-Simarro; Laura Baker; Jennifer Keller-Ramey; Susan M White; Philippe M Campeau; Karen W Gripp; Kerstin Kutsche
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

2.  Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-concept.

Authors:  Jacob P R Jacobsen; Adrianna Oh; Rachel Bangle; Wendy L Roberts; Elizabeth L Royer; Nathan Modesto; Sonora A Windermere; Zixuan Yi; Rebecca Vernon; Manuel Cajina; Nikhil M Urs; Joshua C Snyder; Peter J Nicholls; Benjamin D Sachs; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2019-04-29       Impact factor: 7.853

3.  Brain-Derived Neurotrophic Factor/Tropomyosin Receptor Kinase B Signaling Controls Excitability and Long-Term Depression in Oval Nucleus of the BNST.

Authors:  Dominik Fiedler; Manju Sasi; Robert Blum; Christopher M Klinke; Marta Andreatta; Hans-Christian Pape; Maren D Lange
Journal:  J Neurosci       Date:  2020-11-24       Impact factor: 6.167

4.  In vivo pharmacological manipulation of small conductance Ca(2+)-activated K(+) channels influences motor behavior, object memory and fear conditioning.

Authors:  Kyle A Vick; Michael Guidi; Robert W Stackman
Journal:  Neuropharmacology       Date:  2009-11-24       Impact factor: 5.250

5.  Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2.

Authors:  Adebimpe W Kasumu; Charlotte Hougaard; Frederik Rode; Thomas A Jacobsen; Jean Marc Sabatier; Birgitte L Eriksen; Dorte Strøbæk; Xia Liang; Polina Egorova; Dasha Vorontsova; Palle Christophersen; Lars Christian B Rønn; Ilya Bezprozvanny
Journal:  Chem Biol       Date:  2012-10-26

6.  K(Ca)2 and k(ca)3 channels in learning and memory processes, and neurodegeneration.

Authors:  Els F E Kuiper; Ad Nelemans; Paul Luiten; Ingrid Nijholt; Amalia Dolga; Uli Eisel
Journal:  Front Pharmacol       Date:  2012-06-11       Impact factor: 5.810

7.  A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia.

Authors:  Sabrina Grube; Martin F Gerchen; Bartosz Adamcio; Luis A Pardo; Sabine Martin; Dörthe Malzahn; Sergi Papiol; Martin Begemann; Katja Ribbe; Heidi Friedrichs; Konstantin A Radyushkin; Michael Müller; Fritz Benseler; Joachim Riggert; Peter Falkai; Heike Bickeböller; Klaus-Armin Nave; Nils Brose; Walter Stühmer; Hannelore Ehrenreich
Journal:  EMBO Mol Med       Date:  2011-03-24       Impact factor: 12.137

8.  Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage.

Authors:  Christiano D C Gati; Márcia R Mortari; Elisabeth F Schwartz
Journal:  J Toxicol       Date:  2012-06-04

9.  Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels.

Authors:  Kate Lykke Lambertsen; Jan Bert Gramsbergen; Mithula Sivasaravanaparan; Nicholas Ditzel; Linda Maria Sevelsted-Møller; Aida Oliván-Viguera; Maj Rabjerg; Heike Wulff; Ralf Köhler
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Major channels involved in neuropsychiatric disorders and therapeutic perspectives.

Authors:  Paola Imbrici; Diana Conte Camerino; Domenico Tricarico
Journal:  Front Genet       Date:  2013-05-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.